Narang Mohak, Sah Anjali, Behera Rajendra Kumar, Ramesh Mithun Kumar, Singh Anand Narayan, Madhusudhan Kumble Seetharama
All India Institute of Medical Sciences, New Delhi, India.
Abdom Radiol (NY). 2025 Jun 20. doi: 10.1007/s00261-025-05080-x.
To evaluate the safety and efficacy of radiological interventions for iatrogenic hemobilia.
This retrospective study included 53 patients (mean age: 44.9 years; 32 males, 21 females) who presented with hemorrhagic complications following hepatobiliary interventions (surgical, endoscopic, or radiological) and underwent percutaneous or endovascular embolization between January 2015 and May 2023. The patients were categorized into two groups: Group 1 included patients with a history of surgery, and Group 2 included patients with a history of non-surgical interventions. The clinical-data, imaging-findings, and details of embolization techniques were collected. Technical success and clinical success were assessed along with complications, recurrence, and mortality, and any predictive parameters for these outcomes. Statistical analysis was performed using chi-square and t-tests, with significance set at p ≤ 0.05.
The overall technical success of embolization was 100% and clinical success was 98.1%. There were 17 patients in group 1 and 36 patients in group 2 with a significantly higher incidence of gastrointestinal bleeding (64.7% vs. 19.4%, p = 0.007) and pseudoaneurysms (88.2% vs. 50%, p = 0.013) in group 1. Clinical success was 94.1% in group 1 and 100% in group 2 (p = 0.321). One patient in group 1 had recurrence after a week, which was successfully managed with direct percutaneous n-butyl cyanoacrylate glue embolization. There were no major procedure-related complications. The overall mortality-rate was 13.2% (7/53), with all deaths attributed to the underlying disease. Shock at presentation (p = 0.001) was the sole predictor of mortality on multivariate-analysis (Odds-Ratio = 25.8, Confidence-Interval = 2.2-298.0). No significant difference was observed in recurrence or mortality rates between both the groups.
Radiological interventions are effective and safe for managing iatrogenic hemobilia, with high technical and clinical success rates. Shock on presentation is an independent predictor of mortality, emphasizing the need for urgent and definitive hemostatic control with radiological interventions in such patients.
评估放射介入治疗医源性胆道出血的安全性和有效性。
这项回顾性研究纳入了53例患者(平均年龄:44.9岁;男性32例,女性21例),这些患者在接受肝胆介入治疗(手术、内镜或放射介入)后出现出血并发症,并于2015年1月至2023年5月期间接受了经皮或血管内栓塞治疗。患者分为两组:第1组包括有手术史的患者,第2组包括有非手术介入史的患者。收集了临床数据、影像学检查结果以及栓塞技术的详细信息。评估了技术成功率和临床成功率,以及并发症、复发率和死亡率,以及这些结果的任何预测参数。采用卡方检验和t检验进行统计分析,显著性设定为p≤0.05。
栓塞的总体技术成功率为100%,临床成功率为98.1%。第1组有17例患者,第2组有36例患者,第1组胃肠道出血(64.7%对19.4%,p = 0.007)和假性动脉瘤(88.2%对50%,p = 0.013)的发生率显著更高。第1组的临床成功率为94.1%,第2组为100%(p = 0.321)。第1组有1例患者在一周后复发,通过直接经皮注射正丁基氰基丙烯酸酯胶水栓塞成功处理。没有与手术相关的重大并发症。总体死亡率为13.2%(7/53),所有死亡均归因于基础疾病。多因素分析显示,就诊时休克(p = 0.001)是死亡率的唯一预测因素(比值比=25.8,置信区间=2.2-298.0)。两组之间的复发率或死亡率没有显著差异。
放射介入治疗医源性胆道出血有效且安全,技术成功率和临床成功率高。就诊时休克是死亡率的独立预测因素,强调对此类患者需要通过放射介入进行紧急和确定性的止血控制。